CrushSCI.com
107.5Average days
91Median days
5Fastest days
251Longest days
2302025 publications

Paper Review Records

All Paper Review Records

30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

74 days

EHA Guidelines for the use and reporting of patient‐reported outcomes in clinical trials of classical Philadelphia chromosome‐negative myeloproliferative neoplasms

Authors
Esther Natalie Oliva; Tatyana Ionova; Marta Sobas; Peter Loeffelhardt; Edward Laane; Sam SalekShow moreShow less
Affiliations
1. Hematology Department London North West University Healthcare NHS Trust London United Kingdom; 2. Quality of Life Monitoring Unit Saint Petersburg State University Hospital St. Petersburg Russia; 3. Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation Wroclaw Medical University Wrocław Poland; 4. Global MPN Scientific Foundation Barcelona Spain; 5. Hematology–Oncology Clinic, University of Tartu Tartu Estonia; 6. School of Health, Medicine and Life Sciences University of Hertfordshire Hatfield United KingdomShow moreShow less
Source PDF DOI Publisher page
182 days

Differential recovery of macrophage iron deficiency by oral iron formulations determines inflammation and autocrine hepcidin production in iron‐deficiency anemia

Authors
Ada Antypiuk; Michela Asperti; Richa Sharma; Shobana Navaneethabalakrishnan; Navdeep Jhita; Quentinn Pearce; James E. Cox; Elisa Brilli; Germano Tarantino; Francesca VinchiShow moreShow less
Affiliations
1. Iron Research Laboratory Lindlsey F. Kimball Research Institute, New York Blood Center New York New York United States; 2. Department of Theoretical and Applied Sciences eCampus University Novedrate Como Italy; 3. Department of Molecular and Translational Medicine University of Brescia Brescia Italy; 4. Department of Pediatric Hematology/Oncology Emory University School of Medicine Atlanta Georgia United States; 5. Aflac Cancer and Blood Disorders Center Children's Healthcare of Atlanta Atlanta Georgia United States; 6. Solve Sickle Cell Initiative Atlanta Georgia United States; 7. Department of Biochemistry University of Utah Salt Lake City Utah United States; 8. Metabolomics, Mass Spectrometry, and Proteomics Core University of Utah Salt Lake City Utah United States; 9. Department of R&D PharmaNutra S.p.A. Pisa ItalyShow moreShow less
Source PDF DOI Publisher page
87 days

Maladaptive DNA damage responses impair CD8 T‐cell fitness after allogeneic stem cell transplantation

Authors
Tobias Ronny Haage; Domenica Saul; Romy Böttcher‐Loschinski; Martin Böttcher; Simon Völkl; Andreas Mackensen; Matthias Leisegang; Maurice Michel; Denise Walther; Dimitrios MougiakakosShow moreShow less
Affiliations
1. Department for Hematology, Oncology, Cell‐ and Radiotherapy Otto von Guericke University Magdeburg Germany; 2. Department of Internal Medicine 5, Hematology and Oncology Friedrich Alexander Universität Erlangen‐Nürnberg and Universitätsklinikum Erlangen Erlangen Germany; 3. Department of Oncology and Pathology, Science for Life Laboratory and Center for Molecular Medicine Karolinska Institute and Karolinska Hospital Stockholm Sweden; 4. Magdeburg Center for Cell‐ and Immunotherapy Otto von Guericke University Magdeburg GermanyShow moreShow less
Source PDF DOI Publisher page
72 days

Low tumor burden follicular lymphoma: The state of the art

Authors
Greg Hapgood; Joshua Tobin; Robert Kridel; Brad KahlShow moreShow less
Affiliations
1. Department of Cancer Services Princess Alexandra Hospital Brisbane Queensland Australia; 2. School of Medicine University of Queensland Brisbane Queensland Australia; 3. Princess Margaret Cancer Centre, UHN Toronto Ontario Canada; 4. Division of Medicine Washington University School of Medicine St. Louis Missouri United StatesShow moreShow less
Source PDF DOI Publisher page
224 days

Infections and their determinants in patients with non‐Hodgkin lymphoma receiving bispecific T‐cell antibodies: Results from an international multicenter cohort study

Authors
Zainab Shahid; Michelle Okwali; Ashlee Joseph; David Nemirovsky; Derkach Andriy; Clare Grieve; Rafaella Tringale; Reid Merryman; Aaron Zou; Silvia Ferrari; Monica Rondi; Sean Harrop; Divya Somasekharannair; Jennifer Crombie; Gilles Salles; Giuseppe Gritti; Michael Dickinson; Lorenzo FalchiShow moreShow less
Affiliations
1. Infectious Disease Service Memorial Sloan Kettering Cancer Center New York New York United States; 2. Lymphoma Service Memorial Sloan Kettering Cancer Center New York New York United States; 3. Epidemiology & Biostatistics Memorial Sloan Kettering Cancer Center New York New York United States; 4. Dana Farber Cancer Institute Boston Massachusetts United States; 5. Papa Giovanni XXIII Hospital Bergamo Italy; 6. Peter MacCallum Cancer Centre Melbourne Victoria AustraliaShow moreShow less
Source PDF DOI Publisher page
6 days

“A long bristling road full of adventure, full of discovery” gene therapy approaches in transfusion‐dependent thalassemia: The EHA‐EBMT consensus paper

Authors
Lucia De Franceschi; Emanuele AngelucciShow moreShow less
Affiliations
1. University of Verona and Azienda Ospedaliera Integrata Verona Italy; 2. IRCCS Ospedale Policlinico San Martino Genova ItalyShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does HemaSphere take to review a manuscript?

As of 2026-11-17, CrushSCI has 30 complete review records for HemaSphere. The fastest paper went from submission to acceptance in 5 days (Shooting the messenger: Ecosystem approaches in haematology, received 2026-07-01, accepted 2026-07-06); the slowest took 251 days. The average is 107.5 days and the median is 91 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.